← All companies
CATALYST PHARMACEUTICALS, INC.
CPRX - CIK 0001369568
Market cap$3.84 B
Rank#1606
SEC filings1,337
The table below shows CATALYST PHARMACEUTICALS, INC.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $709.17M | $517.55M | $137.64M | $298.39M | $171.44M | $130.24M |
| Short-term investments | - | - | $0.00 | $0.00 | $19.82M | $10.04M |
| Receivables | $126.48M | $65.48M | $53.51M | $10.44M | $6.62M | $5.99M |
| Inventory | $37.17M | $19.54M | $15.64M | $6.80M | $7.87M | $4.65M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.